| ORIGINAL ARTICLE |
|
| Year : 2016 | Volume
: 10
| Issue : 3 | Page : 182-187 |
|
|
Effect of Homoeopathic treatment on Activity of Daily Living (ADL) in Knee Osteoarthritis: A prospective observational study
FF Motiwala1, Tapas Kundu1, Kamlesh Bagmar1, Vijay Kakatkar2, Yogesh Dhole2
1 Head of Department of Organon of Medicine, Motiwala Homoeopathic Medical College and Hospital, Nashik, Maharashtra, India
2 Ramakrishna Orthopedic Hospital and Research Centre, Nashik, Maharashtra, India
Correspondence Address:
F F Motiwala
Motiwala Homoeopathic Medical College and Hospital, Gangapur Satpur Link Road, via Y.C.M.O.U, Nashik - 422 222, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-7168.188238
|
|
|
Objectives: To investigate the effect of individualized homoeopathic medicines in improving ADL by reducing pain, stiffness and limiting the disease progress. Materials and Methods: 131 consecutive patients with OA of knee were recruited and followed up for minimum period of twelve months. Two orthopaedic surgeons diagnosed the disease based on clinical examination of the patients. Three trained homoeopathic physicians prescribed individualized homoeopathic simillimum and the patients were evaluated for pain on WOMAC Osteoarthritis Index LK3.1 (IK) survey form measuring pain, stiffness and ADL. The pain was also measured on Numerical pain rating scale for confirmation. Result: Individualized homoeopathic medicines prescribed as per law of similia improved the mean ADL from 35.85 to 19.08 (p- 0.0001). Mean pain on WOMAC Osteoarthritis Index survey form improved from 10.50 to 5.48 (p-0.0001). The mean pain score on NRS improved from 6.34 to 3.77 (p-0.0001) and the mean morning stiffness also improved from 4.55 to 2.18 (p-0.0001). Conclusion: Homoeopathic medicines have potential to improve the ADL of OA patients by reducing pain and stiffness and limiting progress of the disease without any adverse systemic effects and can safely be employed as a comprehensive health care therapeutics. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
